MX2012006233A - Nuevos compuestos de espiropiperidina. - Google Patents
Nuevos compuestos de espiropiperidina.Info
- Publication number
- MX2012006233A MX2012006233A MX2012006233A MX2012006233A MX2012006233A MX 2012006233 A MX2012006233 A MX 2012006233A MX 2012006233 A MX2012006233 A MX 2012006233A MX 2012006233 A MX2012006233 A MX 2012006233A MX 2012006233 A MX2012006233 A MX 2012006233A
- Authority
- MX
- Mexico
- Prior art keywords
- spiropiperidine compounds
- novel spiropiperidine
- novel
- compounds
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un compuesto de la fórmula: o una sal del mismo farmacéuticamente aceptable así como también una composición farmacéutica, y un método para tratar la diabetes.(Ver Formula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26518109P | 2009-11-30 | 2009-11-30 | |
PCT/US2010/057359 WO2011066183A1 (en) | 2009-11-30 | 2010-11-19 | Novel spiropiperidine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012006233A true MX2012006233A (es) | 2012-07-03 |
Family
ID=43384775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012006233A MX2012006233A (es) | 2009-11-30 | 2010-11-19 | Nuevos compuestos de espiropiperidina. |
Country Status (25)
Country | Link |
---|---|
US (1) | US8822486B2 (es) |
EP (1) | EP2507228B1 (es) |
JP (1) | JP5709889B2 (es) |
KR (1) | KR101410103B1 (es) |
CN (1) | CN102648195B (es) |
AR (1) | AR078948A1 (es) |
AU (1) | AU2010324987B2 (es) |
BR (1) | BR112012012903A2 (es) |
CA (1) | CA2781292C (es) |
CL (1) | CL2012001321A1 (es) |
CR (1) | CR20120296A (es) |
DO (1) | DOP2012000139A (es) |
EA (1) | EA020507B1 (es) |
EC (1) | ECSP12011930A (es) |
ES (1) | ES2526568T3 (es) |
GT (1) | GT201200164A (es) |
IL (1) | IL219594A0 (es) |
MA (1) | MA33840B1 (es) |
MX (1) | MX2012006233A (es) |
NZ (1) | NZ600203A (es) |
PE (1) | PE20121474A1 (es) |
TN (1) | TN2012000248A1 (es) |
TW (1) | TW201141866A (es) |
WO (1) | WO2011066183A1 (es) |
ZA (1) | ZA201203055B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR078522A1 (es) | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
US8476287B2 (en) | 2009-12-25 | 2013-07-02 | Mochida Pharmaceutical Co., Ltd. | 3-hydroxy-5-arylisothiazole derivative |
JP5809157B2 (ja) | 2010-10-08 | 2015-11-10 | 持田製薬株式会社 | 環状アミド誘導体 |
CN103517898B (zh) | 2011-04-27 | 2015-09-30 | 持田制药株式会社 | 新的3-羟基异噻唑 1-氧化物衍生物 |
JPWO2012147516A1 (ja) | 2011-04-28 | 2014-07-28 | 持田製薬株式会社 | 環状アミド誘導体 |
AR087451A1 (es) * | 2011-08-17 | 2014-03-26 | Lilly Co Eli | Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes |
WO2014159054A1 (en) * | 2013-03-14 | 2014-10-02 | Janssen Pharmaceutica Nv | Gpr120 agonists for the treatment of type ii diabetes |
MX2016006337A (es) | 2013-11-14 | 2016-09-06 | Cadila Healthcare Ltd | Compuestos heterociclicos novedosos. |
US9957219B2 (en) | 2013-12-04 | 2018-05-01 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
US10059667B2 (en) | 2014-02-06 | 2018-08-28 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
KR102445054B1 (ko) | 2018-02-13 | 2022-09-22 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
CA3093130C (en) | 2018-04-19 | 2023-10-17 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
US10774071B2 (en) | 2018-07-13 | 2020-09-15 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
AU2019366355B2 (en) | 2018-10-24 | 2022-10-13 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
CN110590767B (zh) * | 2019-08-29 | 2021-10-08 | 南方科技大学 | 一种合成amg837的方法 |
AU2020363377A1 (en) | 2019-10-07 | 2022-04-21 | Kallyope, Inc. | GPR119 agonists |
UY39222A (es) | 2020-05-19 | 2021-11-30 | Kallyope Inc | Activadores de la ampk |
EP4172162A1 (en) | 2020-06-26 | 2023-05-03 | Kallyope, Inc. | Ampk activators |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0202133D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
MXPA05010724A (es) | 2003-04-04 | 2005-12-15 | Merck & Co Inc | Derivados de las espiropiperidinas aciladas como agonistas del receptor de la melanocortina-4. |
CA2544602A1 (en) | 2003-11-04 | 2005-05-26 | Elixir Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
WO2005086661A2 (en) | 2004-02-27 | 2005-09-22 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
JP4859665B2 (ja) * | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
JPWO2006028239A1 (ja) * | 2004-09-07 | 2008-05-08 | 萬有製薬株式会社 | カルバモイル置換スピロ誘導体 |
TW200821316A (en) * | 2006-07-19 | 2008-05-16 | Astrazeneca Ab | Novel compounds 243 |
US20090247560A1 (en) * | 2006-09-28 | 2009-10-01 | Banyu Pharmaceutical Co., Ltd. | Diaryl ketimine derivative |
EP2125827B1 (en) * | 2006-12-29 | 2010-11-03 | F. Hoffmann-La Roche AG | Azaspiro derivatives |
ES2446419T3 (es) * | 2007-04-16 | 2014-03-07 | Amgen, Inc | Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos |
MX2010004435A (es) | 2007-10-26 | 2010-05-13 | Japan Tobacco Inc | Compuestos espiro y uso farmaceutico de los mismos. |
AR078522A1 (es) * | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
-
2010
- 2010-11-08 AR ARP100104151A patent/AR078948A1/es not_active Application Discontinuation
- 2010-11-10 TW TW099138725A patent/TW201141866A/zh unknown
- 2010-11-19 US US13/505,470 patent/US8822486B2/en not_active Expired - Fee Related
- 2010-11-19 WO PCT/US2010/057359 patent/WO2011066183A1/en active Application Filing
- 2010-11-19 EA EA201290416A patent/EA020507B1/ru not_active IP Right Cessation
- 2010-11-19 NZ NZ600203A patent/NZ600203A/xx not_active IP Right Cessation
- 2010-11-19 ES ES10784390.6T patent/ES2526568T3/es active Active
- 2010-11-19 AU AU2010324987A patent/AU2010324987B2/en not_active Ceased
- 2010-11-19 PE PE2012000730A patent/PE20121474A1/es not_active Application Discontinuation
- 2010-11-19 CN CN201080054116.3A patent/CN102648195B/zh not_active Expired - Fee Related
- 2010-11-19 CA CA2781292A patent/CA2781292C/en not_active Expired - Fee Related
- 2010-11-19 KR KR1020127013788A patent/KR101410103B1/ko not_active IP Right Cessation
- 2010-11-19 EP EP10784390.6A patent/EP2507228B1/en active Active
- 2010-11-19 BR BR112012012903A patent/BR112012012903A2/pt not_active IP Right Cessation
- 2010-11-19 MX MX2012006233A patent/MX2012006233A/es not_active Application Discontinuation
- 2010-11-19 JP JP2012542076A patent/JP5709889B2/ja not_active Expired - Fee Related
-
2012
- 2012-04-25 ZA ZA2012/03055A patent/ZA201203055B/en unknown
- 2012-05-03 IL IL219594A patent/IL219594A0/en unknown
- 2012-05-15 DO DO2012000139A patent/DOP2012000139A/es unknown
- 2012-05-20 EC ECSP12011930 patent/ECSP12011930A/es unknown
- 2012-05-22 TN TNP2012000248A patent/TN2012000248A1/en unknown
- 2012-05-23 CL CL2012001321A patent/CL2012001321A1/es unknown
- 2012-05-28 GT GT201200164A patent/GT201200164A/es unknown
- 2012-05-30 CR CR20120296A patent/CR20120296A/es not_active Application Discontinuation
- 2012-06-21 MA MA34993A patent/MA33840B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2507228B1 (en) | 2014-11-05 |
DOP2012000139A (es) | 2012-08-15 |
KR101410103B1 (ko) | 2014-06-25 |
AU2010324987B2 (en) | 2014-01-30 |
BR112012012903A2 (pt) | 2017-03-01 |
IL219594A0 (en) | 2012-06-28 |
ZA201203055B (en) | 2013-09-25 |
AR078948A1 (es) | 2011-12-14 |
JP2013512277A (ja) | 2013-04-11 |
EP2507228A1 (en) | 2012-10-10 |
CA2781292A1 (en) | 2011-06-03 |
CN102648195B (zh) | 2015-01-07 |
US20120220616A1 (en) | 2012-08-30 |
WO2011066183A1 (en) | 2011-06-03 |
MA33840B1 (fr) | 2012-12-03 |
ECSP12011930A (es) | 2012-07-31 |
GT201200164A (es) | 2014-02-27 |
JP5709889B2 (ja) | 2015-04-30 |
CN102648195A (zh) | 2012-08-22 |
KR20120088770A (ko) | 2012-08-08 |
EA201290416A1 (ru) | 2012-11-30 |
US8822486B2 (en) | 2014-09-02 |
PE20121474A1 (es) | 2012-11-05 |
CA2781292C (en) | 2014-04-22 |
TN2012000248A1 (en) | 2013-12-12 |
NZ600203A (en) | 2013-09-27 |
TW201141866A (en) | 2011-12-01 |
ES2526568T3 (es) | 2015-01-13 |
AU2010324987A1 (en) | 2012-07-26 |
CR20120296A (es) | 2012-07-16 |
EA020507B1 (ru) | 2014-11-28 |
CL2012001321A1 (es) | 2013-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2012000248A1 (en) | Novel spiropiperidine compounds | |
TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
SG178952A1 (en) | Chemical compounds | |
MY149648A (en) | Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
MX2010002419A (es) | (ciclopropilfenil) feniloxamidas, metodo para su produccion y uso como un medicamento. | |
TN2013000434A1 (en) | Novel imidazole derivatives useful for the treatment of arthritis | |
MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
MX2013007336A (es) | Compuestos de bi-heteroarilo como inhibidores de vps34. | |
SG179034A1 (en) | 2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes | |
MY158982A (en) | Heterocyclic compound | |
HK1158192A1 (en) | Piperidine gpcr agonists | |
TN2013000413A1 (en) | Glycoside derivatives and their uses for the treatment of diabetes | |
MX2011008289A (es) | Tabletas para terapia combinada. | |
MY160392A (en) | Triptolide prodrugs | |
WO2010150211A3 (en) | Use of derivatives of indoles for the treatment of cancer | |
NZ700356A (en) | Pyrazole compounds as sglt1 inhibitors | |
MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
JO2979B1 (en) | Cyclopropyl compounds | |
WO2012164055A3 (en) | New compounds, synthesis and use thereof in the treatment of pain | |
NZ589911A (en) | Styrylbenzofuran derivatives as inhibitors for beta-amyloid fibril formation and preparation method thereof | |
TN2010000397A1 (en) | Heterocyclic compounds | |
WO2012008765A3 (ko) | 암 치료 또는 예방용 약학 조성물 | |
UA87608C2 (uk) | Спосіб отримання ціанометилпіримідинів |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |